Judaya, Carlito C.

HRN: 26-79-24  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/12/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/12/2025
03/12/2025
IV
4.5GM
Loading Dose
PNEUMONIA HIGH RISK
Waiting Final Action 
03/12/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/12/2025
03/20/2025
IV
2.25GM
Q8H
PNEUMONIA HIGH RISK
Waiting Final Action 
03/16/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/16/2025
03/19/2025
IVT
2.25g
Q6
Pneumonia HR
Waiting Final Action 
03/16/2025
CLARITHROMYCIN 500MG (CAP)
03/16/2025
03/22/2025
PO
500mg
BID
Pneumonia High Risk
Waiting Final Action 
03/19/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/19/2025
03/22/2025
IV
4.5g
Q8h
CAPHR
Waiting Final Action 
03/25/2025
MUPIROCIN 2%, 15G (TUBE)
03/25/2025
03/31/2025
TOPICAL
0.2%
Bid
Infected Wound
Waiting Final Action 
03/25/2025
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
03/25/2025
03/31/2025
TOPICAL
1%
BID
Infected Wound
Waiting Final Action 
03/27/2025
CEFTAZIDIME 1GM (VIAL)
03/27/2025
04/03/2025
IV
2gms
Q8
CAP HR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: